NASDAQ: VIRVir Biotechnology Inc Stock Ownership - Who owns Vir Biotechnology?
Insider buying vs selling
Have Vir Biotechnology Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Vicki L. Sato | Director | 2025-08-01 | 22,000 | $4.99 | $109.69kSell |
| Mark Eisner | EVP and Chief Medical Officer | 2025-07-17 | 3,586 | $5.47 | $19.63kSell |
| Mark Eisner | EVP and Chief Medical Officer | 2025-07-15 | 6,796 | $5.47 | $37.16kSell |
| Vicki L. Sato | Director | 2025-07-01 | 22,000 | $5.10 | $112.20kSell |
| Janet Napolitano | Director | 2025-06-02 | 3,200 | $5.05 | $16.15kSell |
| Backer Marianne De | Chief Executive Officer | 2025-04-03 | 79,712 | $5.95 | $474.21kSell |
| Verneuil Vanina De | EVP and General Counsel | 2025-02-26 | 7,373 | $9.14 | $67.40kSell |
| George A. Scangos | Director | 2025-02-24 | 10,056 | $9.45 | $95.06kSell |
| Verneuil Vanina De | EVP and General Counsel | 2025-02-24 | 5,140 | $9.45 | $48.59kSell |
| Ann M. Hanly | EVP Chief Technology Officer | 2025-02-24 | 14,168 | $9.45 | $133.93kSell |
VIR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when VIR insiders and whales buy or sell their stock.
VIR Shareholders
What type of owners hold Vir Biotechnology Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Svf Endurance Cayman Ltd | 12.01% | 16,684,041 | $76.25M | Insider |
| Alaska Permanent Fund Corp | 12.00% | 16,666,668 | $76.17M | Insider |
| Blackrock Inc | 11.63% | 16,153,190 | $73.82M | Institution |
| Vanguard Group Inc | 9.52% | 13,227,066 | $60.45M | Institution |
| Temasek Holdings Private Ltd | 3.96% | 5,499,999 | $25.13M | Insider |
| Dhabi Investment Authority Abu | 2.64% | 3,666,666 | $16.76M | Insider |
| Dimensional Fund Advisors LP | 2.17% | 3,007,955 | $13.75M | Institution |
| Melinda Gates Foundation Bill | 2.00% | 2,777,777 | $12.69M | Insider |
| Geode Capital Management LLC | 1.62% | 2,252,420 | $10.29M | Institution |
| Qventures Program II Coinvest Holdings Ltd | 1.20% | 1,666,666 | $7.62M | Insider |
VIR vs Biotech Stocks
Vir Biotechnology Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.